For instance, in subclinical ketosis, downregulation of acetyl-CoA acetyltransferase 2 (ACAT2) (a CoA-dependent enzyme) leads to hepatic triglyceride accumulation and impaired cholesterol synthesis, underscoring how CoA-related molecular events drive metabolic disorders [55]. Here, ACAT2 is linked to metabolic disease.